Swiss pharma giant Roche agrees $7.1 billion deal to buy Telavant Holdings

[ad_1]

A photo showing the logo of Swiss pharmaceutical giant Roche in Basel.

SEBASTIEN BOZON | AFP | Getty Images

Swiss health care company Roche announced it would acquire Telavant Holdings Monday, in a deal worth $7.1 billion.

Telavant creates drugs for people suffering from inflammatory and fibrotic diseases, and is in the process of developing a "promising new therapy" for patients with Crohn's disease, Roche said in a press release.

This is a breaking news story, please check back later for more.

[ad_2] Source link https://worldnews2023.com/top-stories/swiss-pharma-giant-roche-agrees-7-1-billion-deal-to-buy-telavant-holdings/?feed_id=305695&_unique_id=66650006a8e9d

Comments

Popular posts from this blog

Real Housewives of Beverly Hills couple Kyle Richards and Mauricio Umansky ‘seperate’

Perspective | When it comes to this year’s Oscar movies, more is more

Dachshunds and Danes! How the stars are celebrating Christmas this year